HPV vaccine reduces lesion rate in young men by 60%

Vaccination of young men with a multi-strain HPV jab reduces the occurrence of genital lesions, a US study has shown.

The quadrivalent vaccine's efficacy was tested in 4,000 young men (Photograph: SPL)
The quadrivalent vaccine's efficacy was tested in 4,000 young men (Photograph: SPL)

Researchers from the University of California, San Francisco, found a quadrivalent HPV vaccine prevented 60 per cent of young men with the virus from developing genital lesions.

In the UK, there has been debate over the benefits of HPV vaccination for boys after the DoH's joint committee on vaccination and immunisation ruled it was unlikely to be cost effective.

For the study, the researchers enrolled 4,065 healthy males aged 16 to 26 and randomly assigned them to receive either the quadrivalent HPV vaccine or a placebo injection.

The HPV vaccine contained protection against strains HPV-6, 11, 16 and 18. The vaccine or the placebo was administered at the start of the study, then again after two months and after six months.

Participants were checked for presence or absence of external genital lesions caused by infection with HPV.

In total, 36 external genital lesions occurred in the vaccine group, compared with 89 in the placebo group.

Researchers found that 97 per cent of participants given the vaccine had developed antibodies to the virus within a month of administration.

The efficacy of the vaccine was 66 per cent for HPV strains included in the jab. Researchers concluded the vaccine was efficacious at reducing genital lesions in males.

In an accompanying editorial, researcher Jane Kim from the Harvard School of Public Health in Boston said the cost effectiveness of routine vaccination of young men 'will improve if the evidence of efficacy continues to mount'.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

GMC tells BMA to name the doctors responsible for bullying and harassment

GMC tells BMA to name the doctors responsible for bullying and harassment

Senior BMA representatives could face investigation over harassment and bullying...

BMA sexism report backs overhaul to boost representation of women

BMA sexism report backs overhaul to boost representation of women

The BMA should use quotas and minimum thresholds for at least the next decade to...

Key recommendations from the BMA sexism investigation

Key recommendations from the BMA sexism investigation

A damning report into sexism at the BMA, conducted by top barrister Daphne Romney...

Medicines export ban widened as drug shortages continue

Medicines export ban widened as drug shortages continue

The government has added four medicines to the list of products wholesalers are banned...

Damning report on BMA sexism condemns 'failure of leadership'

Damning report on BMA sexism condemns 'failure of leadership'

Whistleblowers have spoken of feeling vindicated after a damning report condemned...

Flawed GP consultation data could distort access targets, BMA warns

Flawed GP consultation data could distort access targets, BMA warns

Flawed data on GP consultations could leave practices facing unfair access targets,...